ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hepatitis B Virus Reactivation Increased the Risk of Developing Hepatic Failure and Mortality in Cirrhosis With Acute Exacerbation

Zhu, Ying; Li, Hai; Wang, Xianbo; Zheng, Xin; Huang, Yan; Chen, Jinjun; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shi, Yu; Shang, Jia; Yan, Huadong; Zheng, Yubao; Qiao, Liang; Zhang, Yan; Xiang, Xiaomei; Dan, Yunjie; Sun, Shuning; Hou, Yixin; Zhang, Qun; Xiong, Yan; Li, Sumeng; Chen, Jun; Huang, Zebing; Li, Beiling; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Gao, Na; Liu, Chunyan; Ji, Liujuan; Yuan, Wei; Li, Jing; Li, Tao; Zheng, Rongjiong; Zhou, Xinyi; Ren, Haotang复旦大学; 华中科技大学; 吉林大学; 南方医科大学; 山东大学; 上海交通大学; 浙江大学; 中山大学; 中国科学院研究生院; 1
Frontiers in Microbiology2022-7-7DOI: 10.3389/fmicb.2022.910549
3被引6阅读
引用收藏
分享

摘要

Background and AimsHepatitis B virus (HBV) reactivation is a serious condition and has been extensively described in chemotherapeutic immunosuppressive population. However, little is known about HBV reactivation in immunocompetent patients with chronic hepatitis B (CHB). In this study, we evaluated the prevalence and the clinical significance of HBV reactivation in CHB patients with acute exacerbations. MethodPatients were screened from two prospective multicenter observational cohorts (CATCH-LIFE cohort). A total of 1,020 CHB patients with previous antiviral treatment history were included to assess the prevalence, risk factors, clinical characteristics of HBV reactivation, and its influence on the progression of chronic liver disease. ResultsThe prevalence of HBV reactivation was 51.9% in CHB patients with acute exacerbations who had antiviral treatment history in our study. Among the 529 patients with HBV reactivation, 70.9% of them were triggered by discontinued antiviral treatment and 5.9% by nucleos(t)ide analogs (NUCs) resistance. The prevalence of antiviral treatment disruption and NUCs resistance in patients with HBV reactivation is much higher than that in the patients without (70.9% vs. 0.2%, and 5.9% vs. 0, respectively, both p < 0.001). Stratified and interaction analysis showed that HBV reactivation was correlated with high short-term mortality in cirrhosis subgroup (HR = 2.1, p < 0.001). Cirrhotic patients with HBV reactivation had a significantly higher proportion of developing hepatic failure (45.0% vs. 20.3%, p < 0.001), acute-on-chronic liver failure (ACLF; 31.4% vs. 21.8%, p = 0.005), and short-term death (14.0% vs. 5.9% for 28-day, and 23.3% vs. 12.4% for 90-day, both p < 0.001) than those without. HBV reactivation is an independent risk factor of 90-day mortality for cirrhosis patients (OR = 1.70, p = 0.005), as well as hepatic encephalopathy, ascites, and bacterial infection. ConclusionThis study clearly demonstrated that there was a high prevalence of HBV reactivation in CHB patients, which was mainly triggered by discontinued antiviral treatment. The HBV reactivation strongly increased the risk of developing hepatic failure, ACLF and short-term death in HBV-related cirrhotic patients, which may suggest that HBV reactivation would be a new challenge in achieving the WHO target of 65% reduction in mortality from hepatitis B by 2030.

学科与关键词

关键词
acute-on-chronic liver failurecohort studyHepatitis B virus reactivationcirrhosismortality
相关
加载中…
  • APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
    Lau, George*; Yu, Ming-Lung*; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; Cheng, Ann Lii; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A. Kadir; Gani, Rino A.; Payawal, Diana A.; Chow, Pierce; Park, Joong-Won; Strasser, Simone, I; Mohamed, Rosmawaiti; Win, Khin Maung; Tawesak, TanwandeeHepatology International, 2021, 15(5): 1031-1048.被引 47
  • Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
    Wang, Tongyu; Tan, Wenting; Wang, Xianbo; Zheng, Xin; Huang, Yan; Li, Beiling; Meng, Zhongji; Gao, Yanhang; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Yan, Huadong; Zheng, Yubao; Zhang, Weituo; Yin, Shan; Gu, Wenyi; Zhang, Yan; Dong, Fuchen; Wei, Jianyi; Deng, Guohong; Xiang, Xiaomei; Zhou, Yi; Hou, Yixin; Zhang, Qun; Xiong, Shue; Liu, Jing; Long, Liyuan; Chen, Ruochan; Chen, Jinjun; Jiang, Xiuhua; Luo, Sen; Chen, Yuanyuan; Jiang, Chang; Zhao, Jinming; Ji, Liujuan; Mei, Xue; Li, Jing; Li, TaoJHEP REPORTS, 2022, 4(10): 100529.被引 7
  • Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization
    Tang, Xiaoting; Qi, Tingting; Li, Beiling; Li, Hai; Huang, Zuxiong; Zhu, Zhibin; Tu, Minghan; Gao, Jie; Zhu, Congyan; Jiang, Xiuhua; Yu, Xutong; Lu, Guanting; Xiong, Ming; He, Qinjun; Zhou, Fuyuan; Wen, Weiqun; Chen, Jinjun*; Hou, JinlinJournal of Gastroenterology and Hepatology, 2021, 36(1): 208-216.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Microbiology
发表日期
2022-07-07
卷期
第 13 卷
页码
910549
DOI
10.3389/fmicb.2022.910549
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81900579, 81930061]; National Science and Technology Major Project [2018ZX10723203, 2018ZX10732202]; Chongqing Natural Science Foundation [CSTC2019jcyj-zdxmX0004]

作者

  • Z

    Zhu, Ying (第一作者)

    third mil med univ

  • L

    Li, Hai

    shanghai jiao tong univ

查看全部 44 位作者收起作者
  • W

    Wang, Xianbo

    beijing ditan hosp · capital med univ

  • Z

    Zheng, Xin

    huazhong univ sci & technol

  • H

    Huang, Yan

  • C

    Chen, Jinjun

  • M

    Meng, Zhongji

    hubei univ med

  • G

    Gao, Yanhang

    jilin univ

  • Q

    Qian, Zhiping

    fudan univ

  • L

    Liu, Feng

    shandong univ

  • L

    Lu, Xiaobo

    1 · xinjiang med univ

  • S

    Shi, Yu

    1 · zhejiang univ

  • S

    Shang, Jia

    henan prov peoples hosp

  • Y

    Yan, Huadong

  • Z

    Zheng, Yubao

    sun yat sen univ

  • Q

    Qiao, Liang

    shanghai jiao tong univ

  • Z

    Zhang, Yan

    shanghai jiao tong univ

  • X

    Xiang, Xiaomei

    third mil med univ

  • D

    Dan, Yunjie

    third mil med univ

  • S

    Sun, Shuning

    third mil med univ

  • H

    Hou, Yixin

    beijing ditan hosp · capital med univ

  • Z

    Zhang, Qun

    beijing ditan hosp · capital med univ

  • X

    Xiong, Yan

    huazhong univ sci & technol

  • L

    Li, Sumeng

    huazhong univ sci & technol

  • C

    Chen, Jun

  • H

    Huang, Zebing

  • L

    Li, Beiling

    southern med univ

  • J

    Jiang, Xiuhua

    southern med univ

  • L

    Luo, Sen

    hubei univ med

  • C

    Chen, Yuanyuan

    hubei univ med

  • G

    Gao, Na

    jilin univ

  • L

    Liu, Chunyan

    jilin univ

  • J

    Ji, Liujuan

    fudan univ

  • Y

    Yuan, Wei

    fudan univ

  • L

    Li, Jing

    shandong univ

  • L

    Li, Tao

    shandong univ

  • Z

    Zheng, Rongjiong

    1 · xinjiang med univ

  • Z

    Zhou, Xinyi

    1 · xinjiang med univ

  • R

    Ren, Haotang

    1 · zhejiang univ

  • Z

    Zhou, Yi

    third mil med univ

  • X

    Xu, Baoyan

    third mil med univ

  • Y

    Yu, Rentao

    third mil med univ

  • T

    Tan, Wenting

    third mil med univ

  • D

    Deng, Guohong

    third mil med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417